1. 569PISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. (23rd October 2018) Authors: Carlsson, G U; Guren, T K; Haux, J; Pfeiffer, P; Taflin, H; Mavroudis, D; Georgoulias, V; Papadimitriou, C; Kentepozidis, N; Boumpas, D; Skintemo, L; Ganlöv, K M E; Gustavsson, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A1.23 IFNα mediated deregulation of mitochondrial DNA clearance as an inciting event for the development of SLE autoimmunity. (24th February 2016) Authors: Gkirtzimanaki, K; Kabrani, E; Mplanas, A; Sidiropoulos, P; Bertsias, G; Boumpas, D; Verginis, P Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A2.23 Deregulated, IFNA driven autophagy shapes the phenotype of autoreactive SLE monocytes. (13th February 2015) Authors: Gkirtzimanaki, K; Kabrani, E; Sidiropoulos, P; Bertsias, G; Boumpas, D; Verginis, P Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A3.15 Reconstituted High Density Lipoprotein (rHDL) Modulates T Effector Cell Function in a Murine Model of Rheumatoid Arthritis. (25th February 2013) Authors: Tiniakou, I; Zannis, VI; Boumpas, D; Verginis, P; Kardassis, D Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A6.34 The role of the costimulatory receptor herpes virus entry mediator (HVEM) in B-cell activation and differentiation. implications for SLE pathogenesis. (13th February 2015) Authors: Seretis, A; Zampoulaki, A; Choulaki, C; Gergianaki, I; Sidiropoulos, P; Boumpas, D; Bertsias, G Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A8.28 Reconstituted high density lipoprotein (RHDL) modulates TH1 and TH17 immune responses and pro-inflammatory cytokine production in a murine model of rheumatoid arthritis. (31st January 2014) Authors: Tiniakou, I; Zannis, V I; Boumpas, D; Verginis, P; Kardassis, D Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort. (15th June 2017) Authors: Fanouriakis, A; Adamichou, C; Koutsoviti, S; Klagou, A; Tsalapaki, C; Konsta, S; Dimopoulou, D; Ntali, S; Vassilopoulos, D; Konstantopoulou, P; Elezoglou, A; Sidiropoulos, P; Erden, A; Bertsias, G; Boumpas, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0471 Wide heterogeneity in treatment protocols and inappropiate use of prednisolone for anti-ro/la associated-congenital heart block: a systematic review of 492 cases. (15th June 2017) Authors: Erden, A; Kilic, L; Bilgin, E; Fanouriakis, A; Ceylan, S; Hymabaccus, B; Sener, YZ; Gurler, F; Sari, A; Armagan, B; Karadag, O; Kiraz, S; Boumpas, D; Kalyoncu, U Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical and financial burden of active lupus in Greece: a nationwide study. (October 2016) Authors: Bertsias, G; Karampli, E; Sidiropoulos, P; Gergianaki, I; Drosos, A; Sakkas, L; Garyfallos, A; Tzioufas, A; Vassilopoulos, D; Tsalapaki, C; Sfikakis, P; Panopoulos, S; Athanasakis, K; Perna, A; Psomali, D; Kyriopoulos, J; Boumpas, D Journal: Lupus Issue: Volume 25:Number 12(2016) Page Start: 1385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Defects within the Myeloid Derived Supressor Cells (MDSCS) Compartment may Facilitate Aberrant Immune Responses in Systemic Lupus Erythematosus (SLE). (22nd February 2012) Authors: Vlachou, K; Fanouriakis, A; Glymenaki, M; Ioannou, M; Mastorodemos, V; Verginis, P; Boumpas, D Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗